Skip to main content

Clinical Trials › NCT00716066

Active, Not RecruitingPhase 2

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Sponsored by Fred Hutchinson Cancer Center

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
53
Target enrollment
2
U.S. states
Jun 2008
Start date
Jan 2030
Expected completion

Interventions / Treatments

Anti-Thymocyte GlobulinAutologous Hematopoietic Stem Cell TransplantationCarmustineCytarabineEtoposideLaboratory Biomarker AnalysisMelphalanPeripheral Blood Stem Cell TransplantationPrednisoneSyngeneic Bone Marrow Transplantation

Conditions studied

Multiple Sclerosis TransplantMS Stem Cell TransplantMultiple Sclerosis Stem Cell Transplant

Where this trial is running (3 sites)

Washington2 sites
Seattle · Seattle
Colorado1 site
Denver

Participating MS centers on MS Buddy (2)

MS centers in Washington

Compare treatment centers near a trial site by center type, providers and trials.

View Washington centers

More Phase 2 trials

Browse all Phase 2 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play